Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

ICG indirectly acquiring stake in €3bn nuclear medicine group

Intermediate Capital Group (ICG) is indirectly acquiring over 25% of the shares of Europe's largest radiopharmaceuticals provider Curium Pharma, HBI can reveal, after owner Capvest earlier pulled a majority sales process because of COVID-19.
October 20, 2020

Veritas Intercontinental raises €5m as it off-shoots from ailing US business

Veritas Intercontinental, the spin-off of US genome sequencing group, Veritas Genetics, has raised €5m from existing investors to help finish building a new lab in Spain. CEO Javier de Echevarría tells HBI that the money will help to establish its independence from its former parent company which temporarily ceased US trading last year. 
October 15, 2020

KRY ‘steals’ patients as it moves into capitated model

Swedish B2C telehealth player Kry has registered 14,000 patients in its first health care centre in Sweden, which comes as it's been forced into the capitated funding system. The start-up has been criticised for not making it clear enough to patients that they would be de-registered from their physical healthcare practice.
October 15, 2020

UBS, EQT, TPG and Icade discuss COVID investment climate

Valuations in the healthcare services sector will roughly stay the same post-COVID, according to a panel of investors from UBS, EQT, Icade Sante and TPG at a HBI-365 panel. That's despite the fact that HBI-365 delegates do not think that deal flow will return to pre-pandemic levels until the second half of next year.
October 15, 2020

Cinven hires banks for Synlab 2021 IPO

HBI hears Synlab's private equity owner Cinven has mandated banks for an initial public offering, expected to take place next year. It will value Synlab at €5bn-6bn.
October 15, 2020

Scandinavian social care specialist buys big in Finland

eQ Care special investment fund has signed an agreement to sell a substantial portfolio of healthcare properties, predominantly elderly and special care homes, to a Scandinavian property fund with a focus on social care.
October 15, 2020

Korian: Inicea a ‘unique opportunity’ with international bolt-ons to follow

Buying France's third-largest private psychiatry group Inicea was a 'unique opportunity' for which a capital raise had to be used, Korian CFO Philippe Garin tells HBI, and international bolt-on acquisitions could follow. He discusses the deal's finances, COVID-19's impact on its regulatory environment, and one reason why Germany might have weathered the pandemic so much better than other countries.
October 15, 2020

NMC could sell by April 2021; Aspen/Eugin by January

NMC Health's administrators Alvarez & Marsal expect to complete a lender-led restructuring or sale of the group by April 2021, and sales of non-core assets - UK hospital chain Aspen Healthcare and international IVF group Eugin - much sooner. It's also revealed the COVID-19 impact on the group's healthcare services revenue.
October 15, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us